A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Zepbound, Mounjaro, and Ozempic can be used for weight loss ... If you have other questions about how these drugs compare, talk with your doctor. They can help you find the best treatment option ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

For more information, see these articles on Wegovy’s dosage and Zepbound’s dosage. Ozempic and Trulicity ... you more about how these medications compare. They can also help determine which ...

Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...

people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who took semaglutide (Ozempic, Wegovy).

Although Novo was first to market with Wegovy and its sister drug Ozempic for diabetes, Lilly has gained the lead in obesity prescriptions with Zepbound ... two medicines compare across different ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether drugs like Wegovy, Ozempic ...